Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company headquartered in Hyderabad, India. Founded in 1984 by Dr. Anji Reddy, the company focuses on providing affordable and innovative medicines. Dr. Reddy's manufactures and markets a broad portfolio of products, including Active Pharmaceutical Ingredients (APIs), generic drugs, biosimilars, and differentiated formulations. Key therapeutic areas include gastro-enterology, cardiovascular, diabetology, oncology, pain management, and dermatology. The company has a global presence, with operations in India, North America, Europe, Russia & CIS countries, and other emerging markets.
The headquarters serves as the core for global strategy, operational oversight, research and development leadership, corporate governance, and central administrative functions for all of Dr. Reddy's international activities.
The Hyderabad campus is known to house advanced research laboratories and modern corporate office spaces designed to foster innovation, collaboration, and operational excellence in the pharmaceutical sector.
The work culture at Dr. Reddy's headquarters, and broadly within the company, emphasizes its core purpose 'Good Health Can't Wait,' fostering innovation, integrity, collaboration, and a patient-first approach. It's generally perceived as a dynamic and growth-oriented environment.
Hyderabad as the headquarters location is significant due to its established ecosystem for pharmaceutical research, manufacturing, and talent, enabling Dr. Reddy's to drive its mission of providing affordable healthcare globally.
Dr. Reddy's Laboratories has an extensive global footprint, with core functions including research and development, manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms, as well as marketing and sales. The company operates in over 66 countries, with key markets in India, North America (USA, Canada), Europe (including UK, Germany), Russia & CIS countries, and various other emerging economies. This widespread presence supports a diverse portfolio of generic medicines, branded generics, biosimilars, and proprietary products aimed at addressing unmet patient needs worldwide.
8-2-337, Road No. 3, Banjara Hills
Hyderabad
Telangana
India
Address: 107 College Road East, Princeton, NJ 08540, USA
Oversees business development, regulatory affairs, and the commercialization of Dr. Reddy's products for the United States and Canadian markets, playing a vital role in the company's global revenue streams.
Address: 410 Cambridge Science Park, Milton Road, Cambridge, CB4 0PE, UK
Functions as an important R&D center and facilitates commercial activities, market access strategies, and regulatory compliance for European markets, contributing to the company's innovation pipeline.
Address: 2nd Tverskaya-Yamskaya str., 18, Bld. 2, Business center “Capital Plaza”, Moscow, 125047, Russia
Focuses on sales, marketing, distribution, and regulatory affairs for Russia and the Commonwealth of Independent States (CIS), tailoring product offerings to regional healthcare needs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Dr. Reddy's Laboratories' leadership includes:
Dr. Reddy's Laboratories has been backed by several prominent investors over the years, including:
Over the past year, Dr. Reddy's Laboratories has focused on strengthening its leadership, particularly in technology and digital transformation, with key appointments. The overall executive structure shows stability with a focus on driving growth and innovation.
Discover the tools Dr. Reddy's Laboratories uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Dr. Reddy's Laboratories commonly utilizes email formats that combine an employee's first name or initial with their last name, followed by the @drreddys.com domain. Variations may exist based on department or region.
firstnamel@drreddys.com (e.g., anilb@drreddys.com) or firstinitiallastname@drreddys.com (e.g. akumar@drreddys.com)
Format
vikasg@drreddys.com
Example
85%
Success rate
Mint • May 7, 2024
Dr. Reddy's Laboratories announced a 36% year-on-year increase in its consolidated net profit to ₹1,307 crore for the fourth quarter ended March 2024. The company's revenue from operations also saw a significant rise of 12% to ₹7,083 crore for the same period. The board recommended a final dividend of ₹40 per share....more
The Economic Times • April 23, 2024
Dr. Reddy's Laboratories announced the dosing of the first patient in a Phase 1/2a clinical study (Pozired 101) of an orally administered investigational drug, IBI362 (DRL17822), for the treatment of patients with advanced solid tumors, including Gastric Adenocarcinoma and Pancreatic Ductal Adenocarcinoma, in the United States....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Dr. Reddy's Laboratories, are just a search away.